Efficacy and blood plasmalogen changes by oral administration of plasmalogen in patients with mild Alzheimer’s disease and mild cognitive impairment: a multicenter, randomized, double-blind, placebo-controlled trial
Fujino T, Yamada T, Asada T, Tsuboi Y, Wakana C, Mawatari S, Kono S.
EBioMedicine. 2017 Mar;17:199-205. doi: 10.1016/j.ebiom.2017.02.012. Epub 2017 Feb 24.
ニュース
2017.02.10